DYNARESOURCE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DYNARESOURCE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.47M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $46.50M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $35.57M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $39.77M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $35.89M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.05M | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | $11.61M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $14.06M | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $10.85M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $9.50M | Apr 16, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.28M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($1.40M) | Apr 2, 2026 |
| FY2013 | Mar 31, 2014 | ($968.6K) | Jun 5, 2014 |
| FY2013 | Mar 31, 2013 | ($895.7K) | Jun 5, 2014 |
| FY2012 | Dec 31, 2012 | ($895.7K) | Apr 12, 2013 |
| FY2012 | Dec 31, 2011 | ($2.65M) | Apr 12, 2013 |
| FY2011 | Dec 31, 2010 | ($3.31M) | Apr 2, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.82M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($8.52M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($14.53M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $6.69M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $8.53M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($5.37M) | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | ($860.8K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($966.7K) | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $2.53M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $1.50M | Apr 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.67M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($6.94M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($15.23M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $2.77M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $13.19M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($2.68M) | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | ($1.65M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($2.53M) | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | ($627.6K) | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $1.52M | Apr 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.76M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($8.01M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($17.66M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($1.78M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $17.52M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($2.42M) | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | ($1.32M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($531.1K) | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $2.06M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $535.1K | Apr 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.61M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $6.8K | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $115.3K | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 16, 2024 |
| FY2020 | Dec 31, 2020 | $0 | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.9K | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $1.27M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $145.0K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $669.4K | Apr 27, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.60M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $38.52M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $35.44M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $40.94M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $28.76M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $11.86M | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | $8.74M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $10.88M | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $11.49M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $9.17M | Apr 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.83M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $31.76M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $25.77M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $21.89M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $23.06M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $17.19M | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | $9.14M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $9.45M | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $7.59M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $8.51M | Apr 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.09M) | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $909.6K | Apr 2, 2026 |
| FY2025 | Dec 31, 2023 | $1.74M | Apr 2, 2026 |
| FY2024 | Dec 31, 2022 | $13.19M | Apr 30, 2025 |
| FY2023 | Dec 31, 2021 | ($151.6K) | Apr 16, 2024 |
| FY2022 | Dec 31, 2020 | ($9.67M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2019 | ($4.73M) | Aug 23, 2022 |
| FY2019 | Dec 31, 2018 | $2.71M | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | $4.98M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | $2.34M | Apr 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($65.35M) | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($69.17M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($58.57M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($44.04M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($50.72M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($59.26M) | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | ($53.95M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($53.15M) | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | ($50.90M) | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | ($53.55M) | Apr 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $15.72M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.50M | Aug 23, 2022 |
| FY2021 | Dec 31, 2019 | $354.6K | Aug 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.69M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $3.53M | Jun 9, 2020 |
| FY2018 | Dec 31, 2016 | $2.20M | Apr 8, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 16, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.32M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | 23.37M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 23.37M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 22.25M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 18.09M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 17.72M | Aug 23, 2022 |
| FY2020 | Dec 31, 2019 | 17.72M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 17.72M | Jun 9, 2020 |
| FY2018 | Dec 31, 2017 | 17.72M | Apr 8, 2019 |
| FY2017 | Dec 31, 2016 | 16.72M | Apr 16, 2018 |